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Action and Traction: Cytoskeletal 
Control of Receptor Triggering at the 
immunological Synapse
William A. Comrie† and Janis K. Burkhardt*
Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Perelman School of Medicine, 
University of Pennsylvania, Philadelphia, PA, USA
It is well known that F-actin dynamics drive the micron-scale cell shape changes required 
for migration and immunological synapse (IS) formation. In addition, recent evidence 
points to a more intimate role for the actin cytoskeleton in promoting T cell activation. 
Mechanotransduction, the conversion of mechanical input into intracellular biochemical 
changes, is thought to play a critical role in several aspects of immunoreceptor trigger-
ing and downstream signal transduction. Multiple molecules associated with signaling 
events at the IS have been shown to respond to physical force, including the TCR, 
costimulatory molecules, adhesion molecules, and several downstream adapters. In at 
least some cases, it is clear that the relevant forces are exerted by dynamics of the T 
cell actomyosin cytoskeleton. Interestingly, there is evidence that the cytoskeleton of the 
antigen-presenting cell also plays an active role in T cell activation, by countering the 
molecular forces exerted by the T cell at the IS. Since actin polymerization is itself driven 
by TCR and costimulatory signaling pathways, a complex relationship exists between 
actin dynamics and receptor activation. This review will focus on recent advances in 
our understanding of the mechanosensitive aspects of T cell activation, paying specific 
attention to how F-actin-directed forces applied from both sides of the IS fit into current 
models of receptor triggering and activation.
Keywords: immunological synapse, actin, cytoskeleton, mechanotransduction, integrin, T cell receptor, adhesion, 
costimulation
iNTRODUCTiON
During their circulation through blood, lymphoid tissues, and peripheral sites of inflammation, 
T cells encounter and respond to a variety of environmental stimuli. Several of these responses are 
dependent on the application of external forces. A good example of this is the shear flow-induced 
activation of cell adhesion molecules during the slow rolling and firm adhesion steps of diapedesis, 
the process that brings cells from the bloodstream into tissues. Following diapedesis, T cells generate 
internal forces that drive their migration through the tissue stroma, in search of antigen-presenting 
cells (APCs) bearing major histocompatibility complex molecules loaded with their cognate peptides 
(pMHC). When T cells recognize these APCs, a specialized adhesive contact known as the immu-
nological synapse (IS) is formed. The IS promotes sustained T cell/APC interactions and serves as 
a platform for exchange of information between the two cells. As with diapedesis and migration, 
T cell/APC adhesion and signal transduction at the IS depend on physical forces exerted by actin 
FiGURe 1 | Organization and actin dynamics within the iS. Diagram 
showing the architecture of a radially symmetric “bulls-eye” IS such as that 
formed between a B cell and an antigen-specific mature T cell. Based on 
molecular segregation, the IS can be divided into three regions: (1) a 
peripheral actin-rich region termed the distal supramolecular activation 
cluster (D-SMAC), (2) a deeper region rich in LFA-1 and actomyosin arcs 
termed the peripheral supramolecular activation cluster (pSMAC), and (3) a 
central region rich in PKCθ and other signaling molecules termed the central 
supramolecular activation cluster (cSMAC). Signaling microclusters 
containing TCR and other signaling molecules (gold balls) form and begin to 
signal in the IS periphery and are transported by the cytoskeleton toward the 
cSMAC region, where signal extinction takes place. Microcluster movement 
is coupled to centripetal flow of the actin network (blue arrows). Actin flow is 
driven primarily by addition of actin monomers to the barbed ends of 
branched actin filaments, which lie just under the plasma membrane. This 
generates a pushing force that drives the network inward. In addition, 
myosin-driven sliding of actin filaments causes contraction of the network. 
This provides a pulling force that stabilizes the network and maintains radial 
symmetry.
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cytoskeletal dynamics. As detailed further below, actin-dependent 
protrusive forces drive close apposition of the two cells, bringing 
receptors on the T cell in contact with ligands on the APC. In 
addition, some IS-associated signaling molecules are physically 
linked to actin filaments; forces exerted on these molecules by 
the actin network result in conformational changes needed for 
full T cell activation.
Signaling at the IS takes place in dynamic microclusters con-
taining surface receptors and downstream signaling molecules. 
These microclusters form at the periphery of the IS, within a 
region rich in branched actin filaments, reminiscent of the lamel-
lipodium found at the leading edge of a migrating cell, and then 
move toward the center of the IS in parallel with centripetal flow 
of the actomyosin network (1). Importantly, ongoing actin flow is 
needed to sustain TCR signaling; if flow is arrested, intracellular 
Ca2+ levels drop, and early signaling intermediates are rapidly 
dephosphorylated (2). Although the signaling events that direct 
F-actin polymerization and cytoskeletal flow at the IS are well 
understood, the mechanism by which actin flow enhances T 
cell activation has remained elusive. Recent studies point to the 
involvement of force-induced receptor activation (3), as well as 
force-driven formation and centralization of signaling microclus-
ters (1, 2, 4, 5). According to this paradigm, early signaling events 
drive the robust polymerization of F-actin at the IS, which in turn 
functions to enhance signal transduction events leading to full T 
cell activation. In this review, we will focus on the mechanisms 
through which cytoskeletal dynamics in T cells and APCs serve to 
control mechanosensitive signaling events at the IS and consider 
how cytoskeletal function can be included in current models of 
receptor triggering.
F-ACTiN DYNAMiCS ON THe T CeLL SiDe 
OF THe iS
During stimulation by an APC, T  cells exhibit robust actin 
polymerization in the periphery of the contact area, centripetal 
(retrograde) flow, and eventual disassembly of F-actin filaments 
near the center of the contact (2, 4) (Figure 1). Consistent with 
this, actin filaments are generally shorter, more branched, and 
more dynamic in the periphery of the IS, where nucleation of 
new actin filaments and polymerization of monomers onto the 
growing ends of existing filaments are occurring (6). Centripetal 
flow of the actomyosin network is primarily driven by the 
polymerization of F-actin, which continuously pushes on the 
plasma membrane (2, 4). This process is accompanied by the 
contractile activity of non-muscle myosin IIA, which organizes 
actin filaments into arcs within the lamellar region. This process 
stabilizes the network and maintains radial symmetry. Under 
conditions where F-actin depolymerization is blocked, myosin 
activity results in network constriction. Simultaneous inhibition 
of F-actin polymerization, F-actin depolymerization, and myosin 
contractility results in complete inhibition of lamellipodial actin 
flow (2, 4). Recently, it has become evident that there are actually 
two pools of dynamic actin filaments at the IS. In addition to 
the prominent lamellipodial pool, actin polymerization also takes 
place in smaller actin foci, structures that are closely associated 
with newly formed TCR microclusters (7). These foci are likely 
equivalent to the podosome- or invadopod-like protrusions 
(ILPs) first visualized in T cells interacting with endothelia, and 
later also found at the T cell/APC interface (8, 9). Although it has 
not been directly demonstrated, it seems likely that the conditions 
shown to arrest lamellipodial actin flow also arrest dynamics of 
these TCR-associated actin foci.
Actin-Regulatory Pathways Downstream 
of the TCR
Within the T cell, multiple signaling pathways, including those 
downstream of the TCR, CD28, and the integrin lymphocyte 
function-associated antigen 1 (LFA-1), lead to the activation 
of actin-regulatory proteins (Figure  2). The relevant signaling 
pathways downstream of the TCR have been reviewed extensively 
(10–12) and will only be briefly discussed here. Following TCR 
engagement, several protein tyrosine kinases, including Lck 
and ZAP-70, are activated, leading to the phosphorylation of 
multiple effectors. One key effector is the scaffold protein linker 
for activation of T  cells (LAT). LAT phosphorylation recruits 
SLP-76 to the IS, and with it the Rho-family GTPase exchange 
factor (GEF) Vav1, the adapter Nck, and the IL-2-inducible T 
cell kinase (Itk). Activation of Vav1 and other GEFs, such as PIX 
and SLAT (13–15), leads to GTP loading and activation of the 
small GTPases CDC42 and Rac1. These GTPases, in turn, recruit 
and activate the actin nucleation promoting factors WASp and 
WAVE2, which work in concert with the related protein HS1 
FiGURe 2 | Regulation of the F-actin network at the iS. Ligation of multiple receptors, including the TCR, the costimulatory molecule CD28, and the adhesion 
molecule LFA-1, results in the induction of robust actin polymerization at the IS. The pathways that mediate F-actin polymerization are highly interdependent. For 
example, the TCR-dependent activation of Lck is involved in initiating CD28-mediated signaling. Moreover, both TCR-induced activation and CD28-induced 
recruitment of PKCθ contribute to LFA-1 activation and downstream signaling. Vav1, a GEF for the critical actin regulators Rac1 and CDC42 and their respective 
effectors WAVE2 and WASp, is triggered in a co-operative fashion downstream of each of these key surface receptors. In addition, signaling events downstream of 
CD28 lead to inhibition of capping protein and activation of cofilin, events that allow growth and remodeling of the branched actin network. Together with HS1, 
WAVE2 and WASp activate ARP2/3 complex-dependent growth of branched actin filaments, forming lamellipodial protrusions and invadopodium-like protrusions, 
respectively. Collectively, these events lead to cell spreading, retrograde actin flow, and formation of the mature IS, along with assembly and centripetal flow of 
TCR-associated signaling microclusters. In addition to triggering actin nucleation, TCR, CD28, and LFA-1 all associate with the F-actin network (proteins known to 
interact with F-actin are denoted by yellow stars). In many cases, these interactions with the F-actin network serve to drive additional signaling events via actin-
dependent feedback loops.
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to orchestrate Arp2/3 complex-dependent polymerization of 
branched actin filaments (16–18).
Interestingly, WASp, WAVE2, and HS1 play distinct roles in 
organizing lamellipodial actin and actin foci. WAVE2 localizes 
strongly to lamellipodial protrusions and is essential for their 
generation (17, 19), whereas WASp is largely dispensable for 
generation of these structures (20). Instead, WASp localizes to 
and is essential for the formation of TCR-associated actin foci 
(7), further extending the similarity between these structures 
and podosomes in other hematopoietic cells (21, 22). The role of 
WAVE2 in generating actin foci cannot be meaningfully tested 
because WAVE2-deficient T cells do not spread in response to 
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TCR engagement, but WAVE2 is absent from these structures (7). 
HS1 can be found in both lamellipodia and actin foci, and in its 
absence, both sets of structures are disordered (7, 16). Thus, it 
appears that WAVE2 organizes lamellipodia that result in T cell 
spreading on the APC, WASp organizes TCR-associated foci that 
protrude into the APC, and HS1 augments and organizes both 
sets of actin-rich structures.
integrin-Mediated Organization of the  
T Cell F-Actin Network
Another effect of TCR signaling is to induce conformational 
changes in LFA-1, an integrin that mediates IS formation and 
firm adhesion (23). LFA-1 engagement initiates a signaling 
cascade that parallels and intersects with the TCR-triggered 
cascade. This process has been termed “outside-in” signaling 
to distinguish it from “inside out signaling” events that trigger 
initial integrin activation downstream of TCR or chemokine 
receptor engagement. Molecules activated downstream of LFA-1 
engagement include FAK, ERK1/2, JNK, and PLCγ1 (24–26). 
LFA-1 regulates F-actin through the ADAP-mediated activation 
of SLP-76 (27–29). This results in F-actin polymerization, likely 
through the Vav-mediated activation of Rac1, CDC42, WASp, and 
WAVE (Figure 2) (30–32). Recruitment of the Arp2/3 complex 
to the site of integrin engagement is enhanced by interactions 
of the complex with the talin-binding protein vinculin (32–34). 
As discussed later, integrin activation and vinculin binding to 
talin are dependent on the interaction of talin with the F-actin 
network and on ongoing F-actin flow. This suggests a robust 
feed-forward loop whereby integrin activation is dependent on 
F-actin-generated forces and results in increased activation of 
F-actin nucleating factors and polymerization at the IS.
Although integrin engagement can induce actin polymeriza-
tion, it can also modulate F-actin flow rates. Engagement of VLA-
4, a β1 integrin expressed on activated T cells, by immobilized 
VCAM-1 greatly decreases the centripetal flow of F-actin at the 
IS (35). This likely occurs through the interaction of multiple 
actin-binding proteins with the β chain of VLA-4, thus linking the 
ligand-immobilized integrin to the F-actin network and retarding 
network flow (35, 36). So, while integrins are capable of nucle-
ating F-actin polymerization, the overall effect on the F-actin 
network will depend on the strength of the outside-in signal, the 
interaction between the integrin cytoplasmic domain and the 
actin network, the viscoelastic properties of the network itself, 
and the mobility of the integrin ligand (since only immobilized 
ligand could oppose forces on the integrin tail).
Costimulatory Signals Leading to F-Actin 
Remodeling
Coligation of the costimulatory molecule CD28 with the TCR 
leads to robust IL-2 production, activation, and expansion of 
naive T  cells (37). The classical pathways involved with CD28 
costimulation have been extensively reviewed (38–41). As part of 
this process, CD28 signaling regulates F-actin dynamics. CD28 
can interact with F-actin through binding to filamin A (Figure 2). 
By binding to the adapter protein Grb-2, CD28 also promotes the 
formation of Vav 1/SLP-76 complexes and initiates downstream 
signaling (42–44). In cells in which Csk, a negative regula-
tor of Lck, has been inhibited, CD28 binding to CD80/86 can 
mediate robust F-actin polymerization (45). CD28-dependent 
F-actin polymerization occurs through Vav-mediated activation 
of CDC42 and is enough to initiate cell spreading, though the 
appearance of the F-actin network is not as symmetrical as with 
TCR stimulation (46). CD28 costimulation has also been shown 
to induce the dephosphorylation and activation of the actin-
severing protein cofilin (47). Somewhat counter-intuitively, actin 
severing by cofilin can increase rates of actin polymerization by 
providing actin monomer and freeing otherwise capped barbed 
ends (48). The overall effect of increasing both F-actin severing 
and polymerization is to create a highly branched F-actin net-
work, a process that can strengthen lamellipodial protrusions 
and contribute to F-actin flow. Another molecule that is likely to 
participate in CD28-dependent actin responses is the lymphoid 
cell-specific actin-uncapping protein, Rltpr. As detailed in Section 
“Regulation of CD28 Signaling by the F-Actin Network,” Rltpr 
interacts with CD28 and plays an essential role in costimulatory 
signaling (49). It remains to be determined if Rltpr functions to 
remove capping protein from barbed ends of actin filaments at 
the IS, but if so, this will also be important for F-actin remodeling.
In addition to CD28, it is likely that many other costimulatory 
proteins also modulate the T cell actin response. One protein 
known to interact extensively with F-actin is CD2. CD2 is 
expressed on the surface of NK cells and T cells, and it can medi-
ate cell adhesion and induce signaling events that promote T cell 
activation (50, 51). Through the cytoplasmic adaptor molecule 
CD2AP/CMS, CD2 engagement can recruit and activate capping 
protein, cortactin and WASp, facilitating the formation of a short, 
branched actin network (52–56).
THe F-ACTiN CYTOSKeLeTON AND THe 
CONTROL OF MOLeCULAR ACTivATiON 
AT THe T CeLL–iS
As detailed above, multiple signaling cascades converge to initiate 
and control F-actin flow at the IS. Conversely, however, F-actin 
dynamics are critical for proper signal transduction. Thus, a posi-
tive feedback loop exists whereby initial signaling events induce 
F-actin restructuring, which in turn reinforces and sustains sign-
aling. In the following sections, we will describe the mechanisms 
by which the F-actin network can control or mediate signaling 
events on the T cell side of the IS.
Maintaining Quiescence in Resting Cells
The maintenance of T  cells in a quiescent state in the absence 
of cognate antigen is critical for the prevention of autoimmunity 
and the proper regulation of the immune response as a whole. 
To maintain quiescence, T cells make use of several mechanisms. 
Based on work in B cells, one likely mechanism involves segrega-
tion of signaling molecules into separate cell surface compart-
ments. As has been shown for the B cell receptor (BCR) (57), the T 
cell actin cytoskeleton may limit baseline signaling by preventing 
clustering of the TCR or downstream signaling intermediates. In 
fact, one way that antigen experienced cells maintain increased 
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sensitivity to antigen is through the oligomerization and cluster-
ing of the TCR, suggesting that this process is, in fact, regulated 
(58). Additionally, it has been reported that large clusters of 
TCR and LAT are maintained separately in resting cells, and 
only overlap upon activation (59). Although LAT clusters are 
maintained by the actin cytoskeleton, it remains possible that 
actin also separates LAT and TCR clusters in resting T cells (60). 
Reorganization of the actin network following stimulation could 
then permit or drive cluster growth and molecular interactions. 
In B cells, actin-binding proteins of the ezrin, radixin, moesin 
(ERM) family limit BCR cluster formation, preventing aberrant 
signaling through the maintenance of diffusional barriers (57). 
BCR signaling transiently deactivates ERM proteins, allowing 
for increased BCR diffusion and cluster formation. This cycle 
is required for antigen capture, as both constitutively active and 
dominant negative ERM proteins interfere with this process (61). 
This shows that while ERM-mediated diffusional barriers may 
aid in maintaining a quiescent state, these barriers also undergo 
a dynamic cycle of activation and deactivation. A similar process 
may be occurring in T cells, since TCR stimulation also causes 
ERM protein dephosphorylation and cytoskeletal relaxation (62).
T Cell Migration, initial Antigen Scanning, 
and the Conversion to a Stable iS
In many experimental systems, T cells are introduced to stimula-
tory surfaces from suspension, such that initial TCR-induced 
actin polymerization is required for cell spreading and synapse 
formation. In vivo, however, initial contact between T cells and 
APCs occurs within the context of T cell migration. T cell migra-
tion requires actin-mediated protrusion of the leading edge and 
myosin-mediated contraction of the trailing uropod (63–65). 
Initial T cell scanning is characterized by short-lived T cell/
APC interactions. During these interactions, T cells form mobile 
synapses known as kinapses, which exhibit protein segregation 
patterns analogous to those seen in mature synapses, but are not 
radially symmetrical (66, 67). In essence, then, the conversion 
between kinapse and synapse entails altering the symmetry of 
the actomyosin network. This appears to be determined, at least 
in part, by the strength of TCR signaling. In support of this, the 
balance between PKCθ signaling and WASp activity determines 
if cells are likely to break or maintain symmetry (68). Although 
additional details of how T cells maintain this balance are yet to 
be worked out, it has been proposed that PKCθ fosters symmetry 
breaking by activating localized myosin contractility (67). In 
addition, there is evidence that intracellular calcium levels also 
play an important regulatory role (69–71).
Coupling of Signaling and Actin-Driven 
Microcluster Dynamics
Following the formation of a stable, symmetric synapse, micro-
clusters of TCR and downstream signaling components, such as 
Zap70 and SLP76, form in the periphery of the IS (peripheral 
supramolecular activation cluster, pSMAC) and undergo trans-
port to the center of the contact zone (central supramolecular 
activation cluster, cSMAC). Depolymerization of F-actin abolishes 
the generation of new TCR microclusters, as well as inward move-
ment of existing TCR microclusters (1, 72), but the mechanisms 
linking the actin cytoskeleton to microcluster formation and 
movement have yet to be fully worked out. Since microtubules 
and cytoplasmic dynein have been implicated in microcluster 
movement toward the cSMAC (73), one could imagine a model in 
which the actin network functions as a static scaffold for micro-
cluster nucleation, with subsequent microtubule-dependent 
microcluster transport contingent upon maintenance of this actin 
scaffold. However, this model has been ruled out; when cells are 
treated with an inhibitor cocktail that arrests actin dynamics 
but leaves the network intact, the formation and translocation 
of SLP76 microclusters are blocked (2). Furthermore, actin flow 
rates are locally perturbed at TCR microclusters that encounter 
a barrier to inward transport (74), suggesting direct interactions 
between the TCR and the actin network. Although it remains 
unclear exactly how actin dynamics promote continued signal-
ing from individual microclusters, arresting F-actin dynamics 
interrupts phosphorylation of PLCγ, resulting in a rapid drop in 
intracellular Ca2+ levels (2). Actin foci are likely to be the relevant 
actin-rich structures in this context, since loss of WASp (or HS1) 
inhibits PLCγ1 activation and associated Ca2+ signaling, while 
loss of WAVE2 affects Ca2+ signaling at the level of CRAC channel 
coupling, leaving PLCγ1 activation intact (17).
In addition to driving microcluster formation and sustaining 
signaling, IS-associated F-actin flow sets a molecular countdown 
for signal termination. Tyrosine phosphorylation of early sign-
aling intermediates typically occurs in microclusters located 
in the pSMAC (72), whereas the cSMAC is an area of protein 
dephosphorylation, ubiquitinylation, and internalization to 
form IS-associated microvesicles (75, 76). Prolonging the time 
microclusters spend in the cell periphery actually prolongs 
signaling lifetime (72, 77). For example, recruitment of TCR 
into the cSMAC is dependent on the ubiquitin-binding protein 
TSG101, and knockdown of TSG101 inhibits cSMAC formation 
and increases microcluster lifetime and total phosphotyrosine 
levels at the IS (76). Thus, while dynamic actin filaments first 
initiate the formation of active signaling microclusters, they 
subsequently lead to their deactivation by driving their accumu-
lation at the cSMAC. Interestingly, formation of TCR-enriched 
microvesicles occurs as a linear function of MHC density (75). 
Moreover, the amount of active signaling that occurs within the 
cSMAC varies with peptide dose and agonist strength (78). Thus, 
signal activation and extinction can be modulated at the level 
of microcluster dynamics, to tune T cell responses over a broad 
range of antigenic signals.
Force Generation and T Cell Activation
During the initial contact between a migrating T cell and an APC, 
and in the radially symmetric mature synapse, multiple forces are 
applied to the molecular contacts between the two cells. As T cells 
migrate on the APC surface, actin polymerization at the leading 
edge and myosin contractility at the trailing uropod provide this 
force, while at the mature IS, the retrograde F-actin flow provides 
a similar force. With this in mind, molecular contacts between 
TCR and pMHC, integrins and integrin ligands, and costimulatory 
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molecules and their ligands must persist and signal under constant 
strain. Interestingly, the generation of molecular forces at the IS 
downstream of pMHC–TCR interactions is directly correlated 
with the antigenicity of a given pMHC (79), and T cells respond 
differently depending on the mechanical properties of the stimu-
latory surfaces they encounter (80, 81). Over the stiffness ranges 
tested so far, it has been shown that human T cells respond better 
to substrates of increasing stiffness, and this corresponds to an 
increased ability to generate force at the IS along with increasing 
substrate stiffness (81, 82). Additionally, migrating T cells are far 
more sensitive to antigen when encountered at the leading edge, 
rather than at the less dynamic uropod, suggesting that the forces 
at the leading edge prime the TCR to respond to cognate antigen 
(83, 84). This evidence suggests that mechanical force is integrally 
involved in T cell activation. If this is the case, then studying 
the mechanical forces on the TCR and other receptors at the IS 
and the relevant mechanosensitive signaling pathways becomes 
critically important in gaining a complete understanding of T cell 
activation.
Cytoskeletal Forces and the initiation and 
Maintenance of TCR Signaling
Although the molecular interactions between the TCR and 
pMHC have been extensively characterized, the mechanism by 
which information on receptor ligation is transmitted across the 
plasma membrane and transformed into the biochemical signals 
associated with TCR triggering is unknown and hotly debated. 
Several challenges unique to the TCR/pMHC interaction must be 
overcome in order to initiate signaling, and any model proposed 
to describe TCR triggering must take these into account (85). 
First, TCR triggering must be extraordinarily sensitive, as there 
are typically only a few molecules of cognate pMHC on the sur-
face of a given APC. Indeed, TCR triggering and T cell activation 
can occur in response to a single pMHC complex (86). Second, 
the TCR must efficiently discriminate between rare agonist and 
plentiful non-agonist pMHC molecules. Finally, TCR triggering 
must occur despite a near limitless diversity in the binding of 
pMHC and TCR. Several models have been proposed to account 
for these requirements. It is illuminating to consider these models 
in terms of the potential role of forces generated by F-actin at the 
IS. It is important to note that many observations that support 
a role for cytoskeletal force can be explained within the context 
of multiple models, and it is likely that several mechanisms are 
working together to initiate TCR triggering.
The Kinetic-Segregation Model
The kinetic-segregation model was proposed, in part, to account 
for the large proportion of Lck that is phosphorylated on the 
activating tyrosine, Y394, even in the absence of TCR stimulation 
(87). It is likely that this active Lck is continuously opposed by the 
action of CD45 and other phosphatases, since pharmacological 
phosphatase inhibition induces T cell activation in the absence of 
TCR stimulation (88–90). Additionally, removal of the Lck nega-
tive regulator C-src tyrosine kinase (Csk) results in the activation 
of proximal TCR triggering events (45). It is therefore unsur-
prising that the balance between tonic signaling and activation 
of TCR signaling depends on the expression of Csk, inhibitory 
phosphatases such as CD45, and kinases such as Lck (91). The 
kinetic-segregation model proposes that close membrane apposi-
tion enforced by the TCR/pMHC bond length (~15 nm) is too 
small to allow colocalization of proteins with large extracellular 
domains, such as CD45. In the model, the TCR is a passive player 
in this process, and close membrane apposition is driven entirely 
by the affinity of TCR for pMHC and the formation of multiple 
bonds leading to stochastic size-based sorting and exclusion of 
large molecules from pMHC/TCR rich areas. Exclusion of CD45 
then allows the system to be dominated by the constantly active 
Lck, and TCR triggering ensues (92). Indeed, in vitro modeling of 
the TCR signaling network on reconstituted liposomes has shown 
that clustering of CD3ζ and Lck is enough to overcome even high 
concentrations of CD45 and induce signaling (93), and large 
ectodomain proteins have been shown to enhance clustering of 
smaller proteins and their ligands in live cells (94). Signaling can 
continue following dissociation of TCR/pMHC as phosphoryl-
ated ITAMs can be protected by interaction with their specific 
binding partners (93).
The strongest evidence for the kinetic-segregation model is 
based on observations that truncation of the CD45 ectodomain 
(creating a shorter molecule) impairs TCR-mediated signaling, 
and that full function can be restored by simply adding any large 
ectodomain to truncated CD45 (95, 96). Additionally, the size 
of the ectodomain influences segregation of CD45 and TCR 
into separate protein islands, with larger ectodomains resulting 
in greater separation. Moreover, extending the length of the 
extracellular domain of pMHC by the addition of various length 
tethers results in poor T cell activation corresponding to greater 
distances between the APC and T cell, and poor exclusion of 
CD45 from both the interfaces and from CD3 clusters (97, 98). 
Though elongated pMHC does not affect TCR or coreceptor 
binding or TCR clustering, it remains possible that elongation of 
pMHC affects the force transduced to the TCR, an idea that will 
be considered below.
Despite the evidence in favor of the kinetic-segregation 
model, several key problems have arisen in the literature. First, 
some authors have found that small ectodomains can result in 
CD45 exclusion from TCR and CD2 microclusters, as well as the 
total IS interface, suggesting that ectodomain size may not be the 
only contributing factor in this process (91, 99). Additionally, 
truncation of the intracellular domain of CD43 results in poor 
exclusion from the IS, suggesting that segregation based on size is 
not enough to determine molecular sorting at the IS for all large 
molecules (100). In these instances, molecular crowding and 
active transport may also be involved. Second, in NK cells, where 
similar molecular sorting events separate inhibitory and activat-
ing receptors based on ectodomain size (101), it has been found 
that segregation depends largely on the surface expression level 
of the small ectodomain protein and its receptor; more expres-
sion (and more receptor–ligand engagement) leading to greater 
segregation (102). This makes sense in that, in order to exclude 
large ectodomain proteins, the combined bond strength between 
shorter molecules and their ligands must be strong enough to 
deform the local plasma membrane and bring cells into close 
proximity, overcoming resistance posed by the entire glycocalyx. 
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Given the generally low affinity of the TCR for pMHC, multiple 
interactions would be needed to provide this force. This idea is 
troublesome given recent evidence that only one pMHC can 
induce the formation of a microcluster containing hundreds of 
TCRs, presumably excluding CD45, on a responding T cell (86). 
Finally, it has been shown that TCR microclusters that exclude 
CD45 can form in the absence of agonist pMHC, and even in 
the complete absence of MHC on artificial surfaces coated with 
ICAM-1 (103). This observation necessitates a different mecha-
nism besides stochastic exclusion of large molecules following 
TCR/pMHC bond formation to explain any size-based exclusion 
of CD45 from TCR microclusters.
The polymerization of the F-actin network and forces gener-
ated by the network may be enough to overcome these limitations. 
During kinapse formation, the T cell actin network is undergoing 
dynamic regulation through a combination of chemokine recep-
tor, costimulatory molecule, and integrin-mediated signaling. 
This reorganization of the F-actin network may be enough to 
push the T cell and APC membranes close together, overcom-
ing the charge repulsion presented by the glycocalyx (104). This 
force could initiate CD45 exclusion from the TCR in areas of close 
membrane apposition, even in the absence of TCR/pMHC inter-
actions. Following TCR engagement, forces generated by F-actin 
polymerization could work in concert with the close membrane 
apposition enforced by TCR/pMHC interactions to propagate 
this process, further separating CD45 and other large ectodomain 
proteins from TCR microclusters, and ultimately excluding them 
from the mature IS. In line with this idea, it has recently been 
found that T  cells can produce invadosome-like protrusions 
into the membrane of an APC. These protrusions can form in 
the absence of antigen (though their frequency and longevity are 
increased in the presence of antigen) and induce extremely close 
membrane apposition, overcoming charge repulsions mediated 
by the glycocalyx (8). Critically, these protrusions (which pre-
sumably correspond to the WASp-dependent actin foci described 
above) are completely dependent on the F-actin network, occur 
in multiple T cell/APC models, and precede the onset of early 
TCR triggering. This phenomenon likely explains why disrup-
tion of the F-actin network prevents the formation of new TCR 
microclusters, even in the continued contact between the T cell 
and an artificial APC (1), since receptor clustering would depend 
on proximity to pMHC, and CD45 exclusion. Based on this evi-
dence, the kinetic-segregation model can be modified to account 
for the contribution of F-actin-generated force in initiating close 
membrane apposition, particularly in the presence of low pMHC 
concentration, thus contributing to CD45 exclusion form sites of 
TCR–pMHC binding (Figure 3A).
The Kinetic Proofreading Model
The kinetic proofreading model of TCR triggering, initially 
proposed by McKeithan, posits that TCR triggering requires 
individual bond lifetimes above a certain threshold duration, 
and longer than the dissociation time (105). Furthermore, if 
unbinding occurs prior to this threshold being reached then no 
signaling occurs and the TCR resets itself. This model was later 
refined to allow for retention of TCR signaling intermediates, 
so that rebinding of pMHC to the same TCR would continue 
from where the previous interaction left off (106). This fits well 
with the observations that fast pMHC on rates can overcome low 
dwell times/high off rates and lead to high apparent affinities and 
TCR triggering. That is, if a pMHC rebinds prior to diffusing 
away from the TCR, it could induce TCR triggering by reaching 
the threshold even when any given interaction is particularly 
short (107, 108). In fact, in 2D experimental paradigms, kon has 
been shown to be one of the best predictors of pMHC agonist 
strength (109, 110).
Force produced by the F-actin network may play an interesting 
role in the kinetic proofreading model. It has recently been shown 
that the TCR can engage in catch-bond molecular interactions, in 
which applied force prolongs the interaction time with cognate 
pMHC (111). In that study, Liu et al. show that in the absence of 
force on the TCR/pMHC bond, there is an inverse relationship 
between the average lifetime of the bond and pMHC potency. 
However, following the application of 10 pN of exogenous force 
to the bond, agonist pMHC bond lifetimes increase, behaving 
like catch-bond molecular interactions, while antagonist bond 
lifetimes decrease, behaving like more traditional slip-bond type 
molecular interactions. This leads to a 57-fold increase in the ratio 
of bond lifetimes between strong agonist and strong antagonist 
peptides following the application of force. Additionally, catch-
bond behavior correlated strongly with the strength of the 
agonist (as measured by T cell stimulatory capacity) such that 
the strongest agonist pMHC had the largest increase in bond 
lifetime following the application of force and required the great-
est force to induce the catch-bond behavior. Interestingly, it has 
been shown that at the IS, the actin cytoskeleton acts to decrease 
the half-life of some TCR/pMHC bonds (109). Thus, internally 
generated force provided by the F-actin network could function 
similarly to the external force applied in the study by Liu et al. In 
terms of the kinetic proofreading model, force would thus allow 
for increased specificity and greater bond lifetimes for agonist vs. 
antagonist pMHC, enhancing sensitivity and diminishing noise 
during TCR signal acquisition (Figure 3B).
The Serial Triggering/Serial Engagement Model
The serial engagement model was proposed as a way of account-
ing for the high specificity of the TCR, despite low 3D affinities 
and high off rates, and low numbers of agonist pMHC on the 
APC surface. In this model, pMHC serially engages with multi-
ple TCRs, triggering each one individually before moving onto 
another, and thereby taking advantage of the high off rate to trig-
ger multiple receptors (112). Later studies have confirmed that 
a single pMHC is capable of recruiting hundreds of TCRs into 
a complex, initiating T cell activation and cytokine production 
(86). It has previously been proposed that actin-induced appo-
sition of the T cell and APC membranes would bring the TCR 
into close proximity to pMHC complexes, accommodating the 
fast on-rates characteristic of agonist pMHC (113). It is possible 
that in addition to facilitating single pMHC/TCR interactions, 
the actin cytoskeleton also serves to bring additional TCRs into 
the immediate vicinity of ligated TCR/pMHC pairs. This would 
increase activation efficiency by reducing the time it would take 
for pMHC to encounter another TCR. The actin cytoskeleton 
is critical for the formation of TCR and signaling microclusters 
AB C
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FiGURe 3 | Mechanisms through which actin-dependent forces can contribute to proposed models controlling TCR triggering. (A)  
The kinetic-segregation model of TCR signaling is dependent on the separation of molecules with small extracellular regions, such as the TCR, from those with large 
extracellular regions, such as the phosphatase CD45. Actin-dependent protrusions would serve to bring the T cell and APC plasma membranes into close proximity, 
thereby driving molecular segregation. This should occur even in the presence of low numbers of cognate pMHC on the APC surface. (B) The kinetic proofreading 
model proposes that TCR triggering is based on longer bond lifetimes for strong agonists than weak agonists. The force-dependent catch-bond behavior of the 
TCR with strong, but not weak, agonist pMHC complexes can enhance bond lifetime for strong agonists, while serving to rupture the slip-bonds formed by TCRs 
engaging weak or non-agonist pMHC. (C) The serial triggering/serial engagement molecule could benefit from the presence of multiple F-actin interactions with the 
TCR. Though it may not be force dependent, the association of the TCR with the F-actin network could lead to clustering of the TCR on the plasma membrane, 
allowing for rapid successive unbinding and rebinding, and serial triggering of multiple TCRs by a single pMHC complex. (D) Several conformational changes that 
have been described for the TCR may be induced or enhanced by the application of force by the T cell actin cytoskeleton. The first posits a mechanical lever-type 
action of the TCR under the application of a tangential force. According to this model, bending of the stiff CD3 chains propagates to the intracellular domain and 
results in signal initiation. The second model suggests that actin associations with the CD3 complex help to pull the CD3 chains away from the inner leaflet of the 
plasma membrane, thus exposing the ITAMs for phosphorylation and binding of essential regulators such as the kinase ZAP70. The third model is based on 
catch-bond molecular interactions between TCR and cognate pMHC complexes. According to this variant of the kinetic proofreading model, cytoskeletal force 
causes a conformational change in the TCR that results in stronger pMHC binding and prolonged or enhanced signaling.
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following simultaneous engagement of multiple TCR molecules 
(1, 2). It is therefore possible that TCR clustering induced by a 
single pMHC is also induced or stabilized by the F-actin network, 
thereby leading to enhanced TCR triggering (Figure 3C). In other 
systems, direct tethering of transmembrane proteins to cortical 
actin induces nanoclustering (114). The TCR associates with the 
F-actin network through both ITAM-dependent and -independ-
ent mechanisms (115–117). Although the ITAM-dependent 
mechanism requires phosphorylation by Lck and is therefore likely 
to take place after initial TCR triggering, the ITAM-independent 
mechanism is mediated by two RRR sequences in the CD3ζ chain 
and causes the constitutive association with F-actin. This associa-
tion is essential for clustering of the TCR, IS formation, and T cell 
activation following TCR engagement. Thus, the constitutive and 
inducible interactions between TCR and F-actin could produce 
localized increases in TCR concentration, thereby facilitating 
serial engagement.
Conformational Change and the 
Mechanical induction of TCR Triggering
Recently, the idea that conformational change and mechano-
sensing may play a critical role in TCR triggering has gained 
significant traction (3, 12, 118). Structural studies demonstrate 
the existence of several conformational changes that can occur 
upon pMHC binding (119–122). In many cases, however, the 
documented changes in TCR structure did not propagate away 
from the pMHC-binding site. Conformational changes in the 
constant domain, away from the antigen-binding site, were sub-
tle, and it remains unclear if these represent conserved changes 
found in all triggering interactions. Furthermore, it is unclear 
how such small changes can propagate to the intracellular portion 
of the CD3 chains. This brings us to the one key problem faced 
by models proposing conformational changes initiated in the 
TCR by pMHC binding alone. Specifically, any conformational 
change must be present in all TCR/agonist pMHC interactions 
and absent from TCR/non-agonist pMHC interactions. Given 
the near limitless variation in the TCR- and pMHC-binding sites, 
it is hard to imagine that all productive interactions occur with a 
given binding geometry necessary to initiate the same structural 
changes. In support of this, activating antibodies can perform 
their function in the absence of any overt structural change to 
the TCR structure in solution (123). Further complicating the 
matter, multiple groups have observed that soluble monomeric 
pMHC is poorly suited to activating T cells, even at extremely 
high concentrations (124–128), despite TCR/pMHC half-lives 
otherwise associated with TCR triggering in a 2D environment 
(109). Finally, as mentioned earlier, simple elongation of the 
pMHC reduces TCR triggering despite maintaining efficient 
binding to the TCR, again suggesting that binding-induced 
conformational change is unlikely to represent a complete TCR 
triggering mechanism. Interestingly, by incorporating slight 
modifications to the conformational change model that take into 
account the cell biology of TCR/pMHC interactions at the IS, one 
can overcome all of these problems (Figure 3D).
Within the IS, the TCR is dynamically associated with the 
F-actin network through multiple direct and indirect interactions 
(Figure 2) (6, 74, 116, 117, 129, 130). These interactions allow 
F-actin-generated force to be applied to the TCR via the actin–TCR 
linkage. Any resistance to this force provided by surface-bound 
pMHC could then be converted into a conserved conformational 
change in the TCR. One key result of refocusing the driver of 
conformational change from molecular interactions occurring 
at the site of pMHC engagement to mechanical force applied 
on the TCR is that these changes in protein structure can occur 
regardless of the specific molecular contacts occurring between 
the TCR and pMHC. As long as the interaction is of sufficient 
affinity to stay bound in the presence of force, productive TCR 
triggering will ensue, thus overcoming the challenge created 
by the diversity in pMHC/TCR interactions. Additionally, this 
mechanism does not require that conformational changes occur 
within the ectodomains of the TCR subunits; it works equally 
well for changes in ITAM-containing intracellular domains (131).
Several lines of evidence support the existence of a mech-
anotransduction-based mechanism for TCR triggering. As 
mentioned earlier, observations that soluble monomeric pMHC 
cannot initiate efficient TCR triggering pose a particular problem 
for the conformational change model (124). Interestingly, surface 
anchoring of monomeric pMHC overcomes this limitation as low 
numbers of surface-bound monomeric pMHC can initiate TCR 
triggering (86, 132, 133). In part, this sensitivity to pMHC and 
continued signaling is dependent on an intact cytoskeleton, as 
addition of actin depolymerizing agents causes rapid loss of cal-
cium flux without loss of IS formation (1, 132, 134). This effect of 
actin inhibition is specific to 2D stimulatory settings, since actin 
depolymerization when the TCR is cross-linked in solution leads 
to prolonged calcium responses (135). Moreover, inhibition of 
cytoskeletal dynamics under conditions that retain the actin scaf-
fold also results in a drop in intracellular calcium (2), showing that 
dynamic actin plays an active role. A likely explanation for these 
observations is that in the 2D setting, as opposed to monomer in 
solution, the dynamic actin filaments can generate force on the 
pMHC/TCR bond, thereby initiating signaling. Supporting this 
idea, tangential force applied on the TCR through non-activating 
antibodies can result in initiation of calcium flux. Strong stimula-
tory anti-CD3ϵ antibodies may mimic this force by binding to 
the side of the complex in a way that induces a bending of the 
CD3 molecule, in contrast to non-activating antibodies that bind 
more perpendicularly at the membrane-distal portion of the CD3 
complex (136). These data support a model in which force on 
the TCR/pMHC complex applied tangentially, and not normally, 
makes the TCR act as a lever, bending and activating the associ-
ated CD3 complexes (Figure 3D, model 1) (137). Critically, the 
actin flow at the IS is radially symmetric and directed toward the 
center of the IS. Force vector measurements at the IS show that 
this actin flow results in a similarly directed force applied to the 
substratum through the TCR (138, 139). This force is consistent 
with the F-actin-driven centralization of TCR microclusters and 
would apply a tangential force on the TCR/pMHC bond.
Interestingly, an external normal force can also initiate TCR 
triggering, though whether normal and tangential forces act by 
the same or different conformational triggering mechanisms 
is unknown (140). Critically, it was shown that simple contact 
between the TCR and pMHC probe was insufficient to induce 
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signaling. Instead, continuous force was required to maintain 
calcium flux; signaling stopped and resumed with the cessation 
and reapplication, respectively, of external force. Consistent with 
this, the loss of TCR triggering that occurs when the extracel-
lular domain of the pMHC is artificially elongated, usually used 
as evidence for the kinetic-segregation model, can be overcome 
through the application of tangential or normal force to the TCR/
pMHC bond. This finding is important in that it suggests that 
prior findings, interpreted as support for the kinetic-segregation 
model, can be reevaluated to fit into a coherent theory of TCR 
triggering based on the application of force on the TCR/pMHC 
bond. Although these findings strongly suggest the existence of 
conformational changes induced through the application of nor-
mal and/or tangential force, the structural nature of these changes 
with each type of force is still unclear. This is complicated by the 
fact that conformational changes under strain are particularly dif-
ficult to study, as they are not likely to exist with pMHC binding 
to purified, soluble, TCR components.
How exactly force is applied to the TCR is an important ques-
tion. As already mentioned, the TCR can interact both directly 
and indirectly with the actin cytoskeleton. The direct association 
of CD3ζ is mediated by two stretches of basic amino acids, and 
mutation of these residues results in decreased synapse forma-
tion and T cell activation (116). Interestingly, these same amino 
acid stretches also mediate binding of the CD3ζ to the negatively 
charged inner leaflet of the plasma membrane, limit the phos-
phorylation of ITAMs (141, 142), and are required for synaptic 
recruitment of CD3 (143). The dual role of the basic stretch sug-
gests a possible competition of binding for the basic residues in 
the CD3ζ cytoplasmic domain, with binding to the inner leaflet 
acting as a negative regulator for activation, and binding to the 
actin cytoskeleton acting as a positive regulator. It also raises the 
possibility that following ligand binding, force exerted by the 
actin cytoskeleton on CD3ζ may physically disrupt the associa-
tion of CD3 chains with the plasma membrane, helping to expose 
the ITAMs for subsequent phosphorylation (Figure 3D, model 
2). Similar binding of the CD3ϵ chain to the plasma membrane 
also restricts phosphorylation of ITAMs within the ϵ chain by 
Lck (144). Though no direct CD3ϵ/F-actin interaction has been 
discovered, it is known that CD3ϵ can bind directly to Nck fol-
lowing TCR engagement prior to detectable phosphorylation 
of ITAMs, and the Nck-binding site is exposed following TCR 
engagement, and independently of TCR signal initiation (131, 
145). This interaction is critical for the initiation of TCR trig-
gering at very early steps, since mutating the residues involved 
in Nck binding or blocking the interaction with cell permeant 
peptides results in greatly diminished phosphorylation of CD3ζ, 
CD3ϵ, and Zap70, reduced recruitment of CD3 to the synapse, 
and inhibition of proliferation and effector function (146, 147). 
Nck is linked to actin polymerization through recruitment and 
binding of N-WASp and WASp (148, 149). Since an N-WASp-
mediated linkage between actin and p130 Cas has been proposed 
to cause the force-dependent activation of p130 Cas (150), it is 
likely that the connection of CD3ϵ to the F-actin network through 
Nck can transduce a similar force. Therefore, CD3ϵ ITAM phos-
phorylation could be regulated by actin-generated force in a way 
similar to the one proposed for CD3ζ.
An alternate model involving normal force stems from recent 
work by Liu et al. demonstrating that TCR/pMHC interactions 
show catch-bond behavior (111). Since many of the theoretical 
mechanisms for catch-bond formation require an accompany-
ing conformational change (151), this study provides strong 
circumstantial evidence for the existence of an as-yet undefined 
conformational change at the site of TCR/pMHC interaction. 
In the study by Liu et al., a tensile normal force was applied by 
retraction of an extracellular probe bearing pMHC, though it 
has been theorized that a similar normal force can be generated 
internally through the action of the F-actin network (118). In this 
case, the F-actin flow at the IS would pull on the TCR, inducing a 
conformational change in the ectodomain that would strengthen 
the interaction with bound pMHC complexes (Figure 3D, model 
3). Even if this conformational change does not initiate signal-
ing, it could enhance the probability of TCR triggering, as in the 
kinetic proofreading model.
Regulation of integrin Function by 
Cytoskeletal Forces
In T cell/APC contacts, integrins are primarily responsible for the 
adhesive interactions that maintain cell–cell contact (152, 153). 
Each integrin consists of an α and a β subunit, paired as shown 
in Figure 4A. In T cells, integrins are required for firm adhesion 
to endothelium during diapedesis and for formation of stable T 
cell/APC interactions, resulting in T cell activation or effector 
function. As such, integrins must function in a variety of extracel-
lular environments, even under the extraordinary strain placed 
on the integrin–ligand bonds by the shear flow in blood vessels. 
Furthermore, integrin activation must be tightly regulated to 
prevent improper lymphocyte function. In general, integrins are 
regulated at two distinct levels: affinity (the strength of interac-
tion between each individual integrin molecule and its ligand) 
and valency (integrin density at the cell–cell interface). Both 
valency and affinity contribute to adhesion (154). Therefore, the 
overall strength of interaction, or avidity, is a product of valency, 
affinity, and relative contact area (155). In T cells, intracellular 
signals emanating from chemokine receptors or the TCR have 
been shown to increase the activation state of integrins on the cell 
surface. This “inside out” signaling can result in either changes 
in valency or affinity, and a large body of work has accumulated 
defining the relevant biochemical pathways (155–157). Recently, 
new data have emerged demonstrating the regulation of integrin 
activation through applied forces (158–160). In the following 
section, the signaling pathways governing integrin activation 
at the IS will be covered, with a particular focus on the role of 
cytoskeletal forces in initiating and sustaining changes in integrin 
valency and affinity.
The αLβ2 (CD11a/CD18) integrin LFA-1 is expressed exclu-
sively in leukocytes and is essential for T-cell trafficking and IS 
formation. In resting T  cells, LFA-1 is maintained in an inac-
tive, bent conformation with very low ligand-binding capacity 
(Figure  4D). Signaling through TCR and CD28 results in the 
activation of the small GTPase Rap1 downstream of PLCγ, PKCθ, 
and CrkL (161–164) (Figure 2). Following Rap1 activation, talin is 
recruited to the IS through the action of RIAM, which links talin to 
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(A) Known α and β integrin chains and pairings. Integrin pairs expressed in leukocytes are depicted in red. (B) Domain structure of the integrin LFA-1. The α chain 
consists of an intracellular tail (cyan), a transmembrane domain (orange), two calf and one thigh domains (gray), and a β-propeller domain (purple) with an inserted 
ligand-binding I domain (pink). The β chain consists of an intracellular tail (cyan), a transmembrane region (orange), a β tail domain (brown), four EGF repeats (yellow), 
a hybrid domain (blue) with an inserted βI domain (green), and a PSI domain (red). (C) Retrograde actin flow drives LFA-1 into the IS from the cell periphery. This 
increases local concentrations of LFA-1, thereby increasing the valency of the interaction and strengthening cell–cell adhesion. (D) LFA-1 can exist in roughly three 
conformations: a bent, low affinity conformation; an extended intermediate affinity conformation; and an extended conformation, where the hybrid domain on the β 
chain is swung outward, allowing for downward movement of the α7 helix in the βI domain. This downward movement allows the βI domain to bind an internal ligand 
in the αI domain, causing downward movement of the αI domain α7 helix and opening of the ligand-binding site. These changes generate a high affinity, extended-
open conformation. Maintenance of this conformation at the IS is dependent on ongoing actin flow, presumably because connection of the β chain intracellular 
domain to the dynamic F-actin network is enough to drive swing-out of the hybrid domain. The resulting force-dependent increase in affinity would promote and 
augment changes induced by ligand binding. (e) In addition to regulating LFA-1 affinity for ligand, applied force can also strengthen the connection of LFA-1 to the 
underlying actin cytoskeleton. Talin, a key protein that links integrins to the actin network, can stretch upon the application of force. This stretching reveals up to 11 
cryptic vinculin-binding sites. Vinculin, itself an actin-binding protein, then binds to the exposed sites and reinforces linkage to the F-actin network.
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the membrane targeting CAAX domain of activated Rap1 (165). 
Recruitment of talin to the IS is required for LFA-1 affinity and 
valency modulation as well as conjugate formation (166). Binding 
of the talin head domain to the cytoplasmic domain of the integrin 
β chain causes alterations to the β transmembrane domain, thereby 
relieving interactions between the α and β chains that maintain the 
bent conformation. This process allows unfolding of LFA-1 and the 
adoption of an intermediate conformation with 10-fold increased 
affinity for ligand over the bent conformation (167–175). This 
“switch-blade” like unfolding occurs in the presence of activating 
antibodies or ligand-mimetic peptides and exposes epitopes that 
report on integrin activation (176, 177). Importantly, overexpres-
sion of the talin head domain is enough to result in extension of 
the majority of LFA-1 molecules on the cell surface, but it does 
not fully rescue cell adhesion, suggesting that the actin-binding 
domain of talin is essential for full LFA-1-mediated cell adhe-
sion (166, 178). In addition to talin, other proteins, including 
members of the kindlin family of adaptors, are known to bind to 
the cytoplasmic domains of integrin β chains and link them to 
the cytoskeleton, further emphasizing that cytoskeletal linkage is 
essential for proper integrin function (160, 179).
The role of the cytoskeleton in mediating changes in LFA-1 
valency is not straightforward. Early studies proposed a mecha-
nism whereby cytoskeletal restraints limited the mobility of LFA-1 
in resting cells, thus preventing clustering. Upon activation, 
cytoskeletal restraints were released, allowing the free diffusion 
and coalescence of LFA-1, thus increasing valency (180–182). In 
this model, the increased association of high affinity LFA-1 with 
the cytoskeleton limits the ability to support firm adhesion (183). 
In support of this idea, low dose Cytochalasin D increases LFA-1 
mobility and clustering and increases cell adhesion to ICAM-
1-coated surfaces. These changes do not induce, and function 
independently of, changes to integrin affinity and conformational 
change (154, 184). Importantly, later studies demonstrated that 
the integrin clustering mediated by actin depolymerization only 
occurs in the presence of ligand, and suggested a trapping mecha-
nism aided by the increased diffusivity of LFA-1 in the absence of 
the cytoskeleton (184). This would indicate that LFA-1 interac-
tion with the cytoskeleton limits valency and is in contradiction 
with the finding that talin, the main link between LFA-1 and the 
cytoskeleton, is required for LFA-1 synaptic accumulation (166). 
Further complicating the picture is the observation that trans-
port of microclusters containing LFA-1 and ICAM-1 at the IS is 
dependent on an intact actomyosin network (4, 185). One of the 
key confounding factors in this literature is that the studies that 
identified the actin cytoskeleton as a negative regulator of LFA-1 
valency were not carried out within the context of an IS. In an IS 
setting, actin retrograde flow can actively draw LFA-1 into the IS, 
increasing the valency of LFA-1/ICAM-1 interactions (Figure 4C).
In addition to the regulation of valency, integrin avidity can 
be regulated at the level of affinity. Changes in integrin affinity 
are generally associated with conformational changes (158) 
(Figure 4D). As previously mentioned, “inside out” regulation of 
integrin extension mediates the transition from the low affinity to 
the high affinity conformation. Conformational change from the 
intermediate to the high affinity state results in a further 100-fold 
increase in affinity for ligand and has been proposed to be medi-
ated by forces generated by the T cell actin cytoskeleton (159, 
175). Structural changes associated with integrin activation have 
been characterized using activating mutations and antibodies 
(176, 186–188). Typically, integrin activation and ligand binding 
are associated with a lateral swing-out of the hybrid domain 
and downward movement of the α7 helix in the βI domain. This 
induces the high affinity conformation of the βI domain and 
has been shown to occur through a series of conformational 
intermediates (189). In αI domain-containing integrins such 
as LFA-1, the activated βI domain binds an invariant glutamate 
residue in the C-linker region between the αI- and β-propeller 
region. This results in downward movement of the αI domain α7 
helix and adoption of the extended open, high affinity, αI domain. 
Importantly, antibodies that stabilize the extended and extended-
open conformations greatly increase LFA-1’s affinity for ligand, 
resulting in a near 1000-fold dynamic affinity range from the bent 
to the extended-open conformations (175, 190). Furthermore, 
shortening of the C-linker region to mimic the downward motion 
exerted by the βI domain results in constitutively active LFA-1 
(187). Steered molecular dynamic simulations have demon-
strated that conversion between different integrin conformations 
can occur through the application of physical forces. Pulling on 
the headpiece or on bound ligand can overcome interactions 
between the hybrid and β-tail domains that help maintain the 
bent conformation, resulting in integrin extension. Importantly, 
forces applied to the headpiece were not sufficient in these 
simulations to induce the opening of the headpiece or separation 
of the integrin legs (191). Interestingly, similar simulations have 
shown that a tensile force applied parallel to the membrane on 
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the β cytoplasmic tail can be propagated along the β chain, result-
ing in hybrid domain swing-out and affinity modulation (188). 
Since talin binds to the integrin β cytoplasmic domain, any force 
applied on LFA-1 through talin’s linkage to the retrograde actin 
flow at the IS would result in a similar tensile force, and should 
mediate integrin affinity maturation (Figure  4E). Intriguingly, 
it is known that high affinity LFA-1 is more tightly bound to 
the actin cytoskeleton than intermediate or low affinity LFA-1, 
supporting the idea that linkage to the underlying cytoskeleton 
is involved in conformational regulation (192). Our recent work 
has demonstrated that, indeed, the force provided by retrograde 
actin flow is critical for maintaining LFA-1 in the high affinity 
conformation, ligand binding, and clustering of LFA-1 at the IS 
(193). Thus, connection of LFA-1 to the dynamic actin network 
provides the force required to initiate integrin recruitment to 
and clustering within the IS, thereby increasing valency, and also 
provides the force to induce conformational change to the high 
affinity state (Figure 4, green arrows).
Consistent with the prediction that force can enhance LFA-1 
affinity, integrins engage in catch-bond interactions (194–196). As 
with other adhesion molecules, such as selectins, integrin bond 
lifetime increases as tensile normal force is applied, until a threshold 
known as critical force is reached, where bonds are rapidly ruptured 
(151, 197). Importantly, blocking binding of the αI internal ligand 
by the open βI domain inhibits catch-bond behavior, suggesting 
that conformational change initiated by hybrid domain swing-out 
is required to initiate catch-bond interactions. Furthermore, it has 
been shown that α5β1 and LFA-1 bond lifetimes are increased 
following a short, transient, period of high force application. 
For LFA-1/ICAM-1 interactions, loading and then unloading of 
applied force stabilizes the integrin/ligand bond, increasing the 
average bond lifetime from 1.5 to over 35 seconds (198).
So far, we have discussed the mechanosenstive aspects of 
LFA-1 regulation with a focus on integrin–ligand interactions. 
Importantly, the connection between the T cell and the APC 
mediated by the integrin–ligand bond is only as strong as the 
weakest link in the pathway (199). Whereas catch-bond interac-
tions between integrins and their ligands exhibit increased affin-
ity with the application of force, the links that connect integrins 
to the cytoskeleton are thought to behave as more conventional 
slip bonds, where force decreases bond lifetime. Nonetheless, the 
talin-mediated linkage of LFA-1 to the actin cytoskeleton is regu-
lated by the application of force. Once talin binds to the integrin 
β tail through its head domain and to F-actin through its rod 
domain, actin–myosin-mediated force pulls on talin. This causes 
talin to unfold like an uncoiling spring, thereby exposing up to 11 
cryptic vinculin-binding sites (200, 201) (Figure 4E). Binding of 
vinculin to the talin rod domain then allows vinculin to bind to 
F-actin and enforces the integrin linkage to the actin cytoskeleton 
(160, 201–204). Although this process is reversible, such that loss 
of force leads to diminished vinculin binding, vinculin binding 
can stabilize the unfolded conformation of talin (205). In T cells, 
vinculin is recruited to the IS and is required for talin recruitment 
and conjugate formation, suggesting that the destabilized talin–
F-actin bond is not enough to maintain LFA-1 activation (206). 
Thus, talin–vinculin binding represents another force-dependent 
step in the pathway leading to integrin activation, and another 
mechanism through which cell adhesion can be enhanced by 
F-actin flow (Figure 4E).
Integrin-mediated outside-in signaling has been mentioned 
earlier as a driver of multiple pathways of T cell activation. 
Importantly, the conformational changes that mediate LFA-1 
affinity maturation are also required for outside-in signal initia-
tion. Blocking LFA-1 affinity maturation leads to decreased IL-2 
production and T cell proliferation (207). Likewise, inhibition of 
the separation of the transmembrane domains through addition 
of an inter-subunit disulfide bond results in the loss of outside-in 
induced stress fiber formation and cell spreading in CHO cells 
(208). Conversely, affinity modulation through the addition of 
conformational change-inducing antibodies results in the same 
pattern of outside-in tyrosine phosphorylation as actual ligand 
binding. This suggests that integrin conformational changes are 
necessary and sufficient to induce outside-in signaling. Therefore, 
forces on the integrin–ligand bond that induce and stabilize 
integrin conformational change are likely to also be required to 
initiate and sustain outside-in signal transduction.
Given the accumulating evidence that physical force exerted 
by the actin cytoskeleton drives conformational changes that 
mediate LFA-1 activation and stabilize this active conforma-
tion, we must re-evaluate our understanding of TCR-mediated 
integrin activation. Under this new paradigm, forces generated 
by the retrograde flow of the T cell actin cytoskeleton act as a 
key component of inside-out signaling and are a critical allosteric 
regulator of integrin activation at the IS.
Regulation of CD28 Signaling by the 
F-Actin Network
As with the TCR and LFA-1, there is strong evidence that F-actin 
contributes to costimulatory signaling at the IS. Here, we will 
focus on CD28, although signaling through CD2 and other 
costimulatory molecules also involves the actin cytoskeleton 
(52–55, 209–211). Microclusters of CD28 form concomitantly 
with TCR microclusters and then segregate into their own 
domain outside of the cSMAC, but the role of F-actin in the 
formation and centralization of these microclusters is unknown. 
Somewhat surprisingly, CD28 microclusters only require the 
presence of ligand to form and centralize and will do so even 
in the absence of the CD28 cytoplasmic tail, though differences 
in the rates were not addressed (212). This suggests that CD28 
microcluster formation is primarily the result of kinetic segrega-
tion. If so, F-actin dynamics could contribute to this process, as 
diagrammed in Figure 5. Regardless of the effects of F-actin on 
CD28 microclusters, several studies indicate that propagation of 
signals downstream of CD28 is dependent on F-actin dynamics. 
First, the F-actin-uncapping protein Rltpr, which interacts with 
CD28, is absolutely required for CD28 signaling. Rltpr-deficient 
mice mimic the phenotype of CD28 knockout mice, and Rlptr is 
required for the CD28-mediated focusing of PKCθ and Carma 1 
within the central region of the IS (49). Second, Tan et al. showed 
in thymocytes that activation of Src kinases by acute inhibition 
of Csk recapitulates many early signaling events in the TCR 
signaling pathway, but does not allow elevation of intracellular 
Ca2+ or ERK phosphorylation (45). Intriguingly, this blockade in 
AB
FiGURe 5 | Regulation of CD28 signaling by applied forces. (A) CD28 clustering at the IS may occur in a signaling-independent manner through the kinetic 
segregation of bound and unbound molecules. Actin polymerization could contribute to this process by generating protrusions that bring the T cell plasma 
membrane into close proximity with that of the APC. In the case of a receptor and a surface bound ligand, the free receptor would occupy less extracellular space 
than the bound receptor–ligand pair, such that bound receptors would be forced to cluster within areas of low membrane proximity. (B) Filamin A (FLNa) is a 
scaffolding protein and an essential CD28 effector that can undergo force-dependent conformational change. Force causes the extension of the second rod domain 
of filamin A, eliminating binding sites that exist in the relaxed protein, and exposing a different set of binding sites that only exist in the extended protein. Thus, under 
tension, FLNa can release low force-binding partners and recruit new proteins to the CD28 signaling complex.
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signaling could be overcome by perturbing the actin cytoskeleton 
or by stimulating CD28-mediated F-actin rearrangement. These 
data support a model in which cortical actin forms a functional 
barrier between active PLC-γ1 and its substrate, and engagement 
of CD28 remodels actin architecture to allow signaling to pro-
ceed. Finally, it has been shown that costimulatory signaling by 
CD28 can induce greater force on stimulatory surfaces than TCR 
triggering alone (presumably through regulation of the F-actin 
network). This additional force is not applied through CD28 itself. 
Instead, force is applied through the TCR, at least in the absence of 
integrin engagement (138). Perhaps CD28 costimulation can lead 
to greater forces on other mechanosensitive receptors, including 
integrins. This idea is consistent with the finding that CD80 and 
CD86 on DCs increase the strength of cell–cell interactions with 
a responding T cell (213).
CD28 interacts with the F-actin cross-linking protein filamin 
A (FLNa) through the PxxPP motif in the CD28 cytoplasmic 
tail and domains 10–12 of FLNa. FLNa is recruited to the IS in a 
CD28-dependent manner following TCR stimulation, and CD28 
interaction with FLNa is required for T cell costimulation (214). 
FLNa is a large, rod-like protein that is composed of an N-terminal 
actin-binding domain and 24 Ig-like domains. Ig-like domains 
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1–15 are referred to as Rod 1, while domains 16–23 make up Rod 
2, with the 24th domain allowing for homodimerization. In addi-
tion to binding actin, FLNa is a prolific scaffolding protein with 
over 90 known binding partners, including intracellular signaling 
molecules, receptors, ion channels, transcription factors, and 
adhesion proteins (215, 216). Critically, many of these interac-
tions can be regulated through the application of either external 
or internally generated force. Cryptic binding sites in the compact 
Rod 2 domain are exposed, and binding sites in the normal state 
are abolished following the application of force. This could occur 
through stretching of the Rod 2 domain under conditions where 
the F-actin network is under stress (216–218). This is particu-
larly relevant at the IS, where the robust F-actin flow is likely to 
apply considerable stress to the network and may represent an 
important force-dependent aspect of CD28-mediated costimula-
tion (Figure  5). Indeed, the mechanical regulation of FLNa-
binding partners sets up several potential signaling mechanisms. 
Molecules that are recruited under force could allow for localized 
signal activation and signal amplification. Conversely, molecules 
that are released following force application could act as soluble 
signaling factors, exerting their function on areas distant from 
the IS. FLNa has been shown to be important for PKCθ recruit-
ment to, and NF-κB-inducing kinase (NIK) activation at, the IS. 
Interestingly, while NIK is constitutively associated with FLNa, 
interaction with PKCθ requires CD3/CD28 signaling. Thus, it 
will be interesting to see if FLNa-mediated CD28 recruitment of 
PKCθ is force dependent.
Force-Based Activation of Other 
Mechanosensitive Molecules at the iS
The preceding sections address force-induced activation of sur-
face expressed receptors and their ligands, but F-actin-generated 
forces affect cytoplasmic molecules as well. One prime example 
is CasL, a lymphocyte-specific member of the Crk-associated 
substrate (Cas) family of proteins. Members of the Cas family 
contain a highly conserved Src kinase substrate domain with mul-
tiple phosphorylatable YxxP motifs. For the non-hematopoietic 
isoform p130Cas, it has been shown that these motifs are exposed 
by mechanical stretching of the protein (219, 220). Stretching of 
p130Cas and exposure/phosphorylation of the Crk-binding site 
is dependent on integrin binding to an immobilized substrate. In 
T cells, phosphorylation of CasL allows binding to Crk and the 
associated GEF C3G, leading to the activation of the small GTPase 
Rap1. Since Rap1 activation induces the recruitment of talin and 
the affinity maturation of multiple integrins, it seems likely that 
CasL functions in a positive feedback loop linking mechanical 
forces on engaged integrins to additional integrin activation.
Two independent studies have demonstrated that myosin con-
tractility is required for maximal CasL phosphorylation, though 
in both studies there was significant CasL phosphorylation left 
at the IS following myosin inhibition (221, 222). Interestingly, 
phosphorylation of Cas within the substrate domain is largely 
independent of myosin contractility, but completely dependent 
on F-actin polymerization (150). It is therefore likely that even in 
the absence of myosin contractility, continued polymerization-
driven F-actin flow at the IS provides sufficient force to drive 
stretch-dependent Cas/CasL activation.
Cytoskeletal Forces May Create Signaling 
Rich and Poor Zones at the iS
Different mechanosensitive receptors can apply varying amounts 
of force on their ligands (223), and the maximum amount of 
force that can be applied is only as strong as the weakest link 
in the complex that links ligand to receptor and receptor to the 
actin network (199). Because of this, the force that allows for 
the greatest signaling for each receptor could be very different 
depending on the strength of these varying molecular interac-
tions. In terms of the IS, TCR–pMHC catch-bonds can withstand 
a maximum force of roughly 10 pN. Unfolding of domain 20 in 
the CD28-binding protein FLNa occurs with the application of 
roughly 15 pN (224), while the integrin–ligand bonds are capable 
of withstanding maximum force of 30 pN (111, 194). Even the 
linkage of vinculin to the talin rod domains has a maximum force 
(~25 pN) that can be applied before unbinding occurs, since the 
talin helices become unstable (225). Since we have shown that 
the F-actin network slows as it moves toward the center of the IS, 
peak force is likely to decrease concomitantly [this assumes that 
force is directly proportional to the rate of F-actin flow, though 
reality may be more complex (199)]. If so, then signaling from 
force-resistant molecules would be initiated and sustained in 
regions of high and moderate F-actin dynamics (i.e., dSMAC and 
pSMAC regions), while molecular interactions with low force 
resistance would only occur in areas of moderate F-actin dynam-
ics (i.e., the pSMAC region). This could set up intrinsic areas of 
maximal signaling for each receptor as microclusters form and 
traverse the IS. Additionally, since F-actin dynamics are poor or 
non-existent in the cSMAC, and the cSMAC represents an area 
of low force generation during the stable phase of IS formation 
(138), this region should not support force-dependent signaling. 
In keeping with this model, TCR microclusters retain their phos-
phorylation in the pSMAC, but become poorly phosphorylated 
in the cSMAC (77). Thus, the distribution of F-actin-generated 
forces at the IS may serve both to initiate signaling and to limit 
ongoing signaling by sweeping microclusters into areas of poor 
F-actin dynamics. In keeping with this, limiting the centralization 
of microclusters and maintaining them in the peripheral F-actin-
rich compartments of the IS enhance microcluster lifetime and 
signaling (77). Additionally, for molecules that engage in catch-
bond molecular interactions, the bond strength and half-life may 
also be regulated across the IS radius, with stronger interactions 
occurring in areas of higher F-actin-generated force, as long as 
that force is not above the rupture force. To really understand 
how changing actin rates and actin-generated forces affect T cell 
signaling differentially across the IS, careful measurements of 
traction forces on different molecules across the IS radius will 
be required.
THe CONTRiBUTiON OF THe DeNDRiTiC 
CeLL CYTOSKeLeTON TO T CeLL 
PRiMiNG
Although a great deal is known about the mechanisms through 
which T cell signaling affects actin dynamics on the T cell side 
of the IS, and vice versa, much less is known about the APC side 
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of the synapse. The APC has long been assumed to be a passive 
partner in IS organization, and until recently, little attention has 
been paid to the possible contribution of the APC cytoskeleton. 
However, recent evidence indicates that at least for DCs, the 
F-actin network plays a critical role in regulating IS-associated 
signaling events leading to T cell activation.
DCs Form Barriers to Lateral Diffusion and 
Control Synaptic Patterns
One area where the DC cytoskeleton is likely to play an active role 
is in regulating IS formation and structure (226). T cells respond-
ing to B cells or stimulatory supported lipid bilayers form the 
classical mature synapse with a characteristic annular pSMAC 
and cSMAC pattern (227, 228). This shows that in the absence of 
barriers to ligand mobility, TCR and LFA-1 microclusters will be 
driven toward the IS center in a T cell autonomous fashion. The 
DC/T cell IS lacks this annular pattern and is instead character-
ized by multiple patches of protein segregation. Even at late time 
points, there is no central accumulation of CD3 (229). Therefore, 
it is highly likely that the DC forms barriers to the free diffu-
sion of T cell ligands that are either cytoskeletal or topological 
in nature. Importantly, these two possibilities are not mutually 
exclusive and the lateral mobility of some proteins could be 
regulated through linkage to the DC actin cytoskeleton, while 
others could be restricted by topological barriers. In either case, 
the DC actin cytoskeleton would play a crucial role in defining 
and maintaining these diffusive barriers. The existence of barriers 
at the DC/T cell IS has important implications for the mechanical 
regulation of signaling. As detailed below, we found that the T cell 
actin cytoskeleton activates mechanosensitive molecules, such as 
integrins, by applying force to the receptor–ligand bond, while 
barriers to diffusion provided by the DC cytoskeleton provide a 
retentive counter force on the ligand, thereby increasing tension 
at the molecular level. Through a similar mechanism, regulation 
of ligand mobility could prevent microcluster centralization 
and deactivation, thereby enhancing T cell activation. Just as 
upregulation of T cell ligands enhances T cell priming by mature 
DCs, control of molecular mobility would serve as a second 
mechanism through which DCs could modulate their T cell 
stimulatory capacity.
The DC Cytoskeleton Plays a Critical Role 
in T Cell Priming
The DC F-actin network has been observed to polarize toward 
a cognate T cell in an MHC-dependent manner (230), and 
treatment of DCs with actin depolymerizing agents impairs the 
DCs ability to prime T cell responses (231). Polarization of the 
DC actin network is mediated by Rho-family GTPases and is 
required for proper conjugate formation, IL-2 production, and 
T cell proliferation (232–234). Similarly, the ARP2/3 complex 
activator WASp promotes the maintenance of T cell–DC inter-
actions; WASp-deficient DCs exhibit fewer and shorter-lived 
contacts with cognate T cells, and a diminished ability to prime T 
cell proliferation (235, 236). Although it is clear that the F-actin 
network on the DC side of the synapse plays a key role in T cell 
conjugate formation and T cell activation, how changes in the DC 
cytoskeleton are regulated, and their role in IS-mediated signal 
transduction are open questions in the field.
Maturation-Associated Changes in the DC 
Actin Network
Following recognition of danger signals through pattern 
recognition receptors, DCs undergo a maturation process that 
increases their stimulatory potential as APCs. Maturation is 
associated with an increase in F-actin content and increased 
plasma membrane ruffling, as well as major changes in actin-
regulatory proteins. The resulting cytoskeletal changes alter anti-
gen uptake and migratory behavior and increase the stimulatory 
potential of DCs by modifying the F-actin network at the DC–IS. 
Among the actin-regulatory proteins that are upregulated dur-
ing maturation are the actin bundling protein fascin, which is 
greatly increased in expression (237, 238), the actin-severing 
protein cofilin, which is activated by dephosphorylation (239), 
and the actin-binding protein moesin, which is increased 
both by enhanced expression and phosphorylation-dependent 
activation (240). Interestingly, there is evidence that fascin and 
cofilin can work together to remodel the F-actin network (241). 
Moreover, fascin polarizes to the site of T cell engagement on 
DCs (231), and we have observed that T cells preferentially bind 
to pre-formed moesin-rich regions (240). It is important to 
point out that in addition to changes in proteins such as fascin, 
cofilin, and moesin that directly bind to actin filaments, DC 
maturation is associated with changes in regulatory molecules 
that control actin dynamics. For example, the activation of the 
Rho-family GTPase CDC42 is diminished during DC matura-
tion (242). Similarly, the semaphorin receptor plexin-A1 is 
upregulated during maturation and is recruited to the DC–IS, 
where it mediates Rho activation, F-actin polarization, and T 
cell activation (234, 243). Going forward, it will be important 
to define how these changes in cytoskeletal proteins and their 
regulators impact DC–IS function. Likely mechanisms include 
physical reorganization of the DC membrane and generation of 
cytoskeletal tethers or corrals that limit the lateral mobility of T 
cell ligands.
Regulated Mobility of T Cell Ligands on 
the DC Surface
Consistent with the idea that activation of T cell surface recep-
tors is force dependent, in vitro analysis shows that modulation 
of ligand mobility can influence T cell activation (244). Though 
comparatively few studies have addressed ligand mobility on 
the DC surface, there is already evidence that ligand mobility is 
regulated in ways that are important for T cell priming.
Control of MHC Lateral Mobility
The strongest evidence that ligand mobility is important for TCR 
triggering comes from studies in which diffusion of an αCD3 anti-
body in stimulatory bilayers is limited by a physical barrier. Under 
these conditions, TCR microclusters are trapped in the periphery 
of the IS, resulting in increased microcluster phosphorylation and 
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cellular activation (77). Interestingly, limiting the forward mobil-
ity of TCR microclusters causes local deformation of the F-actin 
network (6, 74, 245), suggesting that molecular forces between 
the TCR and the viscoelastic actin network are increased.
Though MHC class II lateral mobility is not constrained by the 
F-actin network in B cells or DCs (57, 240), the lateral mobility 
of MHC class I is restricted by the actin cytoskeleton (246–248). 
It is worth noting that many of the studies documenting TCR 
catch-bonds were done using the OTI or 2C CD8 TCR transgenic 
models, suggesting the possibility that TCR mechanotransduc-
tion and control of MHC lateral mobility may be more important 
in MHCI/TCR than MHCII/TCR interactions. It will be interest-
ing to examine the lateral mobility of MHCI in professional APCs 
and to ask if the control of MHCI lateral mobility correlates with 
TCR triggering.
Control of Integrin Ligand Lateral Mobility
As mechanosenstive proteins, integrins respond to the physi-
cal properties of their ligand-binding environment. In fact, 
integrin-mediated cell spreading does not occur unless the 
ligand can withstand roughly 40 pN of applied force (223). In 
line with this idea, stiffness of the extracellular matrix correlates 
with outside in signaling (249), and surface immobilization of 
ICAM-1 is required for TCR-induced LFA-1 conformational 
change (193, 250). Importantly, the lateral mobility of ICAM-1 
can have dramatic effects on immune cell function. In particular, 
NK cells adhere firmly to target cells in which ICAM-1 lateral 
mobility is low, and increasing ICAM-1 mobility decreases the 
efficiency of conjugate formation and lytic granule polarization 
(251). This suggests that restriction of the lateral mobility of 
integrin ligands increases tension on the ICAM-1/LFA-1 bond. 
In endothelial cells, members of the actinin and ERM family 
of actin-binding proteins limit the lateral mobility of ICAM-1 
through interactions with a concerted polybasic region on the 
ICAM-1 cytoplasmic tail. Importantly, the constrained lateral 
mobility of ICAM-1 greatly increases the efficiency of T cell 
diapedesis, suggesting that this is a critical determining factor 
for LFA-1 adhesiveness (252, 253). We have recently shown that 
during DC maturation, ICAM-1 undergoes a specific decrease 
in lateral mobility mediated by interactions with moesin and 
α-actinin, which are upregulated and activated in response to 
inflammatory stimuli (240). This decrease in ICAM-1 lateral 
mobility enhances conjugate formation and LFA-1 affinity 
maturation, and ultimately contributes to T cell priming. This 
evidence indicates that DC maturation is associated with bio-
physical changes that constrain ligand mobility and promote 
mechanical integrin activation.
Control of CD80/86 Lateral Mobility
Constrained lateral mobility of the CD28 ligands CD80 and 
CD86 on the APC surface may also be important for APC func-
tion. Consistent with this idea, the cytoplasmic tails of CD80 and 
CD86 are essential for their costimulatory activity and mediate 
the separation of CD28 microclusters from TCR microclusters 
(254). These tails contain a highly conserved poly-basic motif 
that mediates protein clustering and cytoskeletal interactions 
(255, 256). This motif resembles known ERM-binding sites in 
other proteins, including ICAM-1 (253, 257). Given the impor-
tance of F-actin linkage and reorganization to CD28 function, 
it will be interesting to see if DCs can modulate costimulatory 
signals by regulating the lateral mobility of CD80 and 86.
T Cells and DCs Coordinately Regulate the 
Activation of LFA-1 at the iS
Although there is increasing evidence that the TCR, CD28, and 
integrins can be activated by application of external forces on 
individual receptors, it is critically important to know if the 
molecular forces generated internally at the IS can drive these 
same activation pathways. We have recently shown that T cell 
actin retrograde flow drives conformational change of the inte-
grin LFA-1 into the high affinity form, as well as its accumulation 
and organization at the IS (193). In a reciprocal process, DCs 
actively limit ICAM-1 lateral mobility on the plasma membrane 
through upregulation of the proteins moesin and α-actinin-1 
(240). The limitation on ICAM-1 lateral mobility opposes the 
forces applied by the T cell actin cytoskeleton, thus enhancing 
tension and promoting LFA-1 affinity maturation, T cell adhe-
sion, and priming. Thus, the F-actin networks in the T cell and 
the interacting DC work in concert to efficiently activate the 
integrin LFA-1. Interestingly, coordinated regulation of force 
application on LFA-1 and constrained ICAM-1/ligand lateral 
mobility is also at play during T cell migration on and diapedesis 
through inflamed endothelium (253, 258, 259). The theme that 
appears is that T cell adhesion to either APCs or endothelial 
cells, whether that is brought on by antigen recognition or 
exposure to chemokine, involves both a concerted change in the 
T cell and a reciprocal change in the interacting partner. Thus, 
for mechanosensitive molecules involved in T cell function, the 
physical properties of the ligand on the surface of interacting 
cells must be considered along with the forces applied to the 
receptor itself.
FUTURe DiReCTiONS FOR BASiC AND 
TRANSLATiONAL ReSeARCH
Our understanding of the mechanobiology associated with 
signaling events at the IS is in its infancy. In particular, we lack 
concrete information on how the relevant forces are generated at 
the IS, which molecules act as true mechanosensors, and how the 
function of these molecules is coordinated to tune the immune 
response. Pioneering studies using biophysical approaches, such 
as modulation of substrate stiffness, physical manipulation using 
micropipettes, and traction force measurements, have all been 
informative (81, 138, 260), and there is much work yet to do in 
this arena.
To relate these biophysical measurements to T cell signal-
ing, we also need to develop additional probes for protein 
conformation and activation state. For example, antibodies 
specific for integrin activation intermediates have been quite 
valuable (175, 193), as have antibodies that detect stretching 
of Cas (150, 222). Conformational probes for integrins and 
Cas family members have been successful because these pro-
teins undergo large scale, concerted, changes as part of their 
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regulated function. Given the paucity of robust conformational 
changes that are detectible in the ectodomains of the TCR, it 
is unsurprising that similar reagents do not exist for the study 
of TCR mechanosensing. One conformation-specific antibody 
has been reported for the TCR, though this epitope is exposed 
upon pMHC binding even in force-free conditions (131). 
Building upon work showing that agonist mAbs bind to the 
membrane-distal CD3ϵ lobe and exert torque on the CD3 
complex (136), it may be possible to ask if cytoskeletal forces 
on TCRs engaged to pMHC have a similar effect by measur-
ing changes in binding of anti-CD3ϵ Fabs in the presence or 
absence of F-actin dynamics. In any case, it seems likely that 
analysis of TCR force sensing will continue to be challenging, 
and that novel tools that detect changes transmitted across the 
cell membrane will be needed.
One caveat to the use of conformation-specific antibodies 
is that they often induce or stabilize the conformations they 
detect. This considerably limits their use, especially in live 
cell experiments. Thus, future studies are likely to require 
fluorescent tension biosensors for live cell microscopy similar 
to those that have been used to detect force on vinculin (261). 
This technology is evolving rapidly (262, 263). FRET-based 
biosensors have already been used to detect activation of 
VLA-4 in migrating T cells (263), and similar biosensors have 
been used to create integrin ligands that register force applied 
by spreading cells (264, 265). Another ligand-based approach 
involves a tension gauge tether consisting of a piece of double 
stranded DNA attached to an integrin ligand on one strand 
and to the substratum on the other such that the DNA strands 
separate with applied force, which can be varied over a range 
of 12–56  pN (223). Related ligand-based force sensors could 
be extremely useful in measuring the forces applied to specific 
receptor–ligand pairs, and the effects of cytoskeletal perturba-
tions on these forces.
As a closing note, it is worth considering how new knowledge 
about the mechanobiology of T cell signaling could influence 
immunotherapy. Recent clinical successes have generated great 
interest in T cell-based immunotherapies for cancer and infec-
tion (266, 267). Although many approaches exist for adoptive T 
cell therapy, a common first step involves the ex vivo expansion 
of T cell subsets, typically through the use of stimulatory beads. 
Much thought has gone into optimizing the antibody cocktails 
used for bead coating, but relatively little attention has been paid 
to their physical properties. Yet, these properties are likely to 
be highly significant. For example, most stimulatory magnetic 
beads commercially available for T cell activation are ~4 μm in 
diameter; yet, human peripheral blood T  cells engaging APCs 
readily spread to a diameter of 12  μm and resting blasts can 
spread to over 20 μm. A bead that is not large enough to induce 
robust spreading is not likely to induce the symmetric actin 
flow associated with mechanical signaling. Thus, beads with a 
larger surface area may enhance T cell activation and expansion. 
Another key parameter is the rigidity of the stimulatory surface. 
Human T cells reportedly respond better on softer surfaces, with 
increased IL-2 secretion, proliferation, and effector function 
increasing upon decreased cell surface rigidity (81). Interestingly, 
the substrate rigidity range used in this study was 100–1000 kPa, 
several orders of magnitude above physiological values for soft 
lymphoid tissues. Further research aimed at optimizing surface 
area and rigidity may prove valuable in creating artificial APCs 
for clinical applications.
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